UK braces for growth in demand for LDR (low dose rate) prostate brachytherapy for prostate cancer
This article was originally published in Clinica
Executive Summary
New UK National Health Service guidelines supporting low dose rate (LDR) brachytherapy for localised prostate cancer appear to have caught the Department of Health by surprise, obliging it to launch a consultation on how best to ensure services can meet an expected significant rise in demand for the procedure.